Bio-Techne (TECH) Asset Writedowns and Impairment (2012 - 2025)

Bio-Techne's Asset Writedowns and Impairment history runs 5 years deep, the most recent figure standing at $84.2 million for Q2 2025.

• In Q2 2025, Asset Writedowns and Impairment rose 428.46% year-over-year to $84.2 million; the TTM figure through Jun 2025 stood at $96.4 million (up 505.51% YoY), while the FY2025 annual figure was $80.5 million, up 266.54% from the prior year.
• Asset Writedowns and Impairment for Q2 2025 stood at $84.2 million, up from -$3.7 million in the prior quarter.
• The five-year high for Asset Writedowns and Impairment was $84.2 million in Q2 2025, with the low at -$3.7 million in Q1 2025.
• The 3-year median for Asset Writedowns and Impairment is $15.9 million (2024), against an average of $23.1 million.
• Peak annual rise in Asset Writedowns and Impairment reached 428.46% in 2025, while the deepest fall reached 428.46% in 2025.
• Bio-Techne's Asset Writedowns and Impairment stood at $18.7 million in 2021, then retreated by 14.91% to $15.9 million in 2024, then surged by 428.46% to $84.2 million in 2025.
• Business Quant data shows TECH's Asset Writedowns and Impairment at $84.2 million in Q2 2025, -$3.7 million in Q1 2025, and $15.9 million in Q2 2024.